SENESCHAL, Julien; BONIFACE, Katia

doi:10.5826/dpc.1304S2a313S

SENESCHAL, Julien
Immunology from Concept and Experiments to Translation = Immunologie Conceptuelle, Expérimentale et Translationnelle [ImmunoConcept]

BONIFACE, Katia

Immunology from Concept and Experiments to Translation = Immunologie Conceptuelle, Expérimentale et Translationnelle [ImmunoConcept]

Idioma

Article de revue

Este ítem está publicado en

Dermatology Practical and Conceptual. 2023, vol. 13

Resumen en inglés

The current management of vitiligo remains challenging; however, different strategies can be proposed to patients with a good efficacy in many cases. First, it is important to identify patients in the active phase of the disease because treatment should start as soon as possible to halt its progression. For patients with a stable disease, the treatment strategy is now well-stratified and is based on a combination of phototherapy (natural or in a cabin) and topical immunomodulatory agents. Surgical treatments are useful for localized and stable vitiligo, as well as for segmental vitiligo. Depigmentation remains indicated in very extensive forms. The recent approval of topical ruxolitinib cream in both the US and Europe brings new approaches for the management of vitiligo and paves the way for the development of new topical or oral targeted drugs.< Leer menos

Palabras clave en inglés

Vitiligo

Management

Treatment

URI

https://oskar-bordeaux.fr/handle/20.500.12278/201840

DOI

http://dx.doi.org/10.5826/dpc.1304S2a313S

Centros de investigación

ImmunoConcEpT - UMR 5164

Ver/Abrir

Metadatos

Compartir este ítem

Licencia de uso del documento

Vitiligo: Current Therapies and Future Treatments

Idioma

Este ítem está publicado en

Resumen en inglés

Palabras clave en inglés

URI

DOI

Centros de investigación